High validity leadership Verantos positions itself as the market leader in high-validity real-world evidence across therapeutic areas, indicating a strong value proposition for biotech and pharma clients seeking research-grade RWE at scale.

Regulatory and market access The platform is designed to generate evidence suitable for market access, medical affairs, and regulatory use, presenting opportunities to sell to teams navigating payer approvals, labeling, and post-market surveillance.

Expansion through partnerships Past partnerships, such as with Curimeta, and recent registry launches like the Inflammatory Bowel Disease Pragmatic Registry, suggest potential for co-developed studies and data collaboration with biopharma and specialty networks.

Growth and recognition Consistent Inc. 5000 recognitions imply solid growth traction and investor confidence, which can be leveraged in outreach to larger enterprise customers seeking proven RWE capabilities.

Data technology readiness Tech stack including AI, workflows, and scalable data integration signals readiness to handle diverse data sources, enabling sales conversations about integration into existing health data ecosystems and compliance frameworks.